INTEGRATION OF EBOLA VIRUS DISEASE SURVIVORS ASSOCIATION IN THE POST EBOLA STRATEGY IMPLEMENTATION: FROM PREVIOUS EXPERIENCE ON HIV/AIDS TO EBOLA VIRUS DISEASE INTEGRATION OF EBOLA VIRUS DISEASE SURVIVORS ASSOCIATION IN THE POST EBOLA STRATEGY IMPLEMENTATION: FROM PREVIOUS EXPERIENCE ON HIV/AIDS TO EBOLA VIRUS DISEASE Raoul Emeric Guetiya Wadoum 1, 2, 3,4 * , Nadege Goumkwa Mafopa 2,3 , Marta Giovanetti 1,3,5 , Gianluca Russo 6 , Martin Sanou Sobze 2 , Antonella Minutolo 1 , Patrick Turay 7 , Joseph Turay 4 , Mahmoud Kargbo 8 , Thomas Turay 7 , Mohamed Thomas Kanu 9 , Brima Kargbo 10 , James Akpablie 11 , Carrie Jo Cain 12 , Paola Pasin 13 , Cinzia Cecchini 14 , Alberto Cresci 14 , Carla Montesano 1,3 , Vittorio Colizzi 1 1 University of Rome “Tor Vergata”, Rome, Italy; 2 University of Dschang, Dschang, Cameroon; 3 Molecular Biology and Immunology Laboratory (MBIL), Makeni, Sierra Leone; 4 University of Makeni, Makeni, Sierra Leone; 5 National Institute of Health – ISS, Rome, Italy; 6 University of Rome “La Sapienza”, Rome, Italy; 7 Holy Spirit Hospital, Makeni, Sierra Leone; 8 Partner Relief Development, Freetown, Sierra Leone; 9 Sierra Leone Association of Ebola Survivors Bombali Branch (SLAESB); 10 Sierra Leone Ministry of Health and Sanitation (MoHS); 11 World Health Organization (WHO); 12 World Hope International (WHI); 13 ENGIM Italian cooperation; 14 Synbiotec S.R.L., University of Camerino, Italy The extraordinary commitment, social mobilisation and lobby of HIV/AIDS patient associations induced the implication of politicians, government and Non Governmental Organization (NGO) to provide funding, guidelines, strong containment and involvement of pharmaceutical companies resulting in an unprecedented scale-up of HIV/AIDS prevention, treatment, care, and support [1]. Although these impressive gains and universal access to treatment for HIV/AIDS patients is not available worldwide [2], Ebola survivors associations can learn and construct basic program activities with direct effect on reduction of stigmatisation and increase of clinical assessment of Ebola survivors and Ebola-contacts. We believe that a rapid transfer of technologies and human resources from HIV/AIDS to EVD research could highly improve scientific understanding and better management of side effects they suffer. INTRODUCTION UNESCO Merck Africa Research Summit- MARS,19th and 20th of October 2015 Geneva, Switzerland Researchers across the world should come together to discuss the generation, sharing and dissemination of research data and integrate patients association in defining new policies . Such successful integration has been achieved with HIV/AIDS patients association and actually transfers successfully to Ebola survivors association in Makeni, Sierra Leone. REFERENCES RESULTS EXLUDED CLINICAL FOLLOW-UP VIRAL LOAD MEDICATION POSITIVE RT-PCR IN BIOLOGICAL FLUID POSITIVE NEGATIVE CONSEILLING FOR ABSTINENCE AND USE OF CONDOM HBV, HCV, HIV, CMV NEGATIVE POSITIVE ADMISSION OF EBOLA VIRUS DISEASE SURVIVORS FROM THE SANDALOKO CHIEFDOM AND SHEBORA CHIEFDOM BOTH IN THE BOMBALI DISTRICT ANTI-ZEBOV NP IgG NEGATIVE TRANSAMINASE (ALAT, ASAT) CLINICAL FOLLOW-UP ABNORMAL NORMAL SET-UP AND INAUGURATION OF THE MOLECULAR BIOLOGY AND IMMUNOLOGY LABORATORY (MBIL) MATERIALS AND METHODS ETHICAL CLAIRANCE FROM THE SIERRA LEONE ETHIC SCIENTIFIC AND REVIEW COMITTEE AND SIGNING AN MoU WITH THE EBOLA SURVIVORS ASSOCIATION BOMBALI DISTRICT BRANCH Figure 1: MoU between Prof. V. Colizzi head of the MBIL and the president of Ebola survivors association Figure 2: Training of health care workers of Ebola survivors clinic by scientists from MBIL Figure 3: Providing results to Ebola survivors and explanation through culture mediated channels Figure 4: Education, sensitization of the population in other to reduce the stigmatization of Ebola survivors and facilitate their social reintegration CONCLUSION UNICEF. Children and AIDS: fifth stocktaking report, 2010. New York, NY, USA: UNICEF, 2010. United Nations. Report of the Secretary-General: uniting for universal access: towards zero new HIV infections, zero discrimination and zero AIDS-related deaths. http://www.unaids .